Gene · 252995
Papers4,118
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,118
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploration of the Potential Biomarker FNDC5 for Discriminating Heart Failure in Patients with Coronary Atherosclerosis. | J Cardiovasc Transl Res | 2024 | 38376700 | PubTator, text mining | PubMed |
| Investigation of new inflammatory biomarkers in patients with brucella. | PLoS One | 2024 | 38359069 | PubTator, text mining | PubMed |
| A case-control study to evaluate irisin levels in patients with type 1 diabetes mellitus. | Ir J Med Sci | 2024 | 38349510 | PubTator, text mining | PubMed |
| Cerebral Benefits Induced by Electrical Muscle Stimulation: Evidence from a Human and Rat Study. | Int J Mol Sci | 2024 | 38339161 | PubTator, text mining | PubMed |
| Role of hydrogen sulfide in the regulation of lipid metabolism: Implications on cardiovascular health. | Life Sci | 2024 | 38336275 | PubTator, text mining | PubMed |
| The Role of FNDC5/Irisin in Cardiovascular Disease. | Cells | 2024 | 38334669 | PubTator, text mining | PubMed |
| Plausible prediction of renoprotective effects of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney diseases. | J Int Med Res | 2024 | 38329077 | PubTator, text mining | PubMed |
| Role of irisin and myostatin on sarcopenia in malnourished patients diagnosed with GLIM criteria. | Nutrition | 2024 | 38309190 | PubTator, text mining | PubMed |
| Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer's disease. | J Neuroinflammation | 2024 | 38308368 | PubTator, text mining | PubMed |
| Enhanced reparatory effect of EI1 on dental pulp via extracellular matrix remodeling by miR-181b-2-3p inhibitor. | J Dent Sci | 2024 | 38303812 | PubTator, text mining | PubMed |
| Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma. | BMC Urol | 2024 | 38297313 | PubTator, text mining | PubMed |
| Effect of acute resistance exercise on bone turnover in young adults before and after concurrent resistance and interval training. | Physiol Rep | 2024 | 38296351 | PubTator, text mining | PubMed |
| Impact of Exercise Intensity on Cerebral BDNF Levels: Role of FNDC5/Irisin. | Int J Mol Sci | 2024 | 38279218 | PubTator, text mining | PubMed |
| High-Protein Diets during either Resistance or Concurrent Training Have No Detrimental Effect on Bone Parameters in Resistance-Trained Males. | Nutrients | 2024 | 38276563 | PubTator, text mining | PubMed |
| Impact of Nutritional Status of Patients with Head and Neck Squamous Cell Carcinoma on the Expression Profile of Ghrelin, Irisin, and Titin. | Cancers (Basel) | 2024 | 38275878 | PubTator, text mining | PubMed |
| The Role of Adipokines in the Control of Pituitary Functions. | Animals (Basel) | 2024 | 38275812 | PubTator, text mining | PubMed |
| Non-Thyroidal Illness in Chronic Renal Failure: Triiodothyronine Levels and Modulation of Extra-Cellular Superoxide Dismutase (ec-SOD). | Antioxidants (Basel) | 2024 | 38275651 | PubTator, text mining | PubMed |
| Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review. | Diabetes Metab J | 2024 | 38273789 | PubTator, text mining | PubMed |
| A novel injectable hydrogel prepared from phenylboronic acid modified gelatin and oxidized-dextran for bone tissue engineering. | Int J Biol Macromol | 2024 | 38272405 | PubTator, text mining | PubMed |
| Injectable Self-Healing Oxidized Starch/Gelatin Hybrid Hydrogel for Preventing Aseptic Loosening of Bone Tissue Engineering. | ACS Appl Mater Interfaces | 2024 | 38270092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/252995/papers?page=40